The National Academies’ Guidelines for Human Embryonic Stem Cell Research, which guided UW–Madison’s own policy on human pluripotent stem cell research, encourages all institutions to create a Stem Cell Research Oversight Committee to provide oversight of all issues related to derivation and use of human embryonic stem cell lines and to facilitate the education of investigators involved in human embryonic stem cell research. The guidelines further suggest that the Stem Cell Research Oversight Committee could be internal to a single institution or established jointly with one or more other institutions. Alternatively, an institution may have its proposals reviewed by the Stem Cell Research Oversight Committee of another institution, or by an independent Stem Cell Research Oversight Committee.
Not all institutions have established a Stem Cell Research Oversight Committee in response to the guidelines. In recognition of the fact that UW–Madison faculty and staff may collaborate on human pluripotent stem cell research with investigators at other institutions that do not have such a committee, and that UW–Madison believes it is important for all activities of investigators who collaborate with UW–Madison faculty and staff on such research to be fully vetted by such a committee, the UW–Madison Stem Cell Research Oversight Committee adopts the following policy.
When UW–Madison faculty and staff engage in research as described in Section 1 of the UW–Madison human pluripotent stem cell research policy which involves multiple sites, the following applies:
UW-4025 UW–Madison Policy for Human Embryo and Human Pluripotent Stem Cell Research